Astrana Health Completes Acquisition of Collaborative Health Systems
Astrana Health, Inc. (NASDAQ: ASTH) has completed its acquisition of Collaborative Health Systems (CHS), previously a Centene (NYSE:CNC) company. This strategic move expands Astrana's provider network and value-based care capabilities across 17 states, serving over 129,000 beneficiaries. The acquisition aims to:
1. Enhance payer-agnostic care delivery across all business lines
2. Integrate complementary provider footprints in key markets
3. Leverage Astrana's Care Enablement platform to improve patient outcomes
Brandon Sim, CEO of Astrana Health, emphasized that this acquisition will strengthen the company's position in delivering high-quality, accessible healthcare. The transaction has received necessary regulatory approvals, with updated financial outlooks to be provided in Astrana's Q3 2024 earnings call.
Astrana Health, Inc. (NASDAQ: ASTH) ha completato l'acquisizione di Collaborative Health Systems (CHS), precedentemente una società di Centene (NYSE:CNC). Questa mossa strategica espande la rete di fornitori di Astrana e le capacità di assistenza basata sul valore in 17 stati, servendo oltre 129.000 beneficiari. L'acquisizione ha l'obiettivo di:
1. Migliorare la fornitura di assistenza indipendentemente dal pagatore su tutte le linee di business
2. Integrare le orme dei fornitori complementari nei mercati chiave
3. Sfruttare la piattaforma di Abilitazione all'Assistenza di Astrana per migliorare gli esiti dei pazienti
Brandon Sim, CEO di Astrana Health, ha sottolineato che questa acquisizione rafforzerà la posizione dell'azienda nella fornitura di assistenza sanitaria di alta qualità e accessibile. La transazione ha ricevuto le necessarie approvazioni regolatorie, con previsioni finanziarie aggiornate che saranno fornite nella conference call sugli utili del terzo trimestre 2024 di Astrana.
Astrana Health, Inc. (NASDAQ: ASTH) ha completado la adquisición de Collaborative Health Systems (CHS), anteriormente una compañía de Centene (NYSE:CNC). Este movimiento estratégico expande la red de proveedores de Astrana y las capacidades de atención basada en el valor en 17 estados, sirviendo a más de 129,000 beneficiarios. La adquisición tiene como objetivo:
1. Mejorar la entrega de atención independiente del pagador en todas las líneas de negocio
2. Integrar huellas de proveedores complementarios en mercados clave
3. Aprovechar la plataforma de Habilitación de Cuidado de Astrana para mejorar los resultados de los pacientes
Brandon Sim, CEO de Astrana Health, enfatizó que esta adquisición fortalecerá la posición de la empresa en la entrega de atención médica de alta calidad y accesible. La transacción ha recibido las aprobaciones regulatorias necesarias, con perspectivas financieras actualizadas que se proporcionarán en la llamada de ganancias del tercer trimestre de 2024 de Astrana.
Astrana Health, Inc. (NASDAQ: ASTH)는 Collaborative Health Systems (CHS)의 인수를 완료했습니다. 이는 이전에 Centene (NYSE:CNC) 회사였습니다. 이번 전략적 움직임은 Astrana의 제공자 네트워크와 17개 주 전역에서 129,000명 이상의 수혜자에게 값 기반 치료 능력을 확대합니다. 인수의 목표는 다음과 같습니다:
1. 모든 비즈니스 라인에서 지불자에 관계없는 치료 제공 강화
2. 주요 시장에서 보완적인 제공자 발자취 통합
3. Astrana의 치료 지원 플랫폼을 활용하여 환자 결과 개선
Astrana Health의 CEO인 Brandon Sim은 이번 인수가 회사의 고품질, 접근 가능한 의료 제공 위치를 강화할 것이라고 강조했습니다. 이번 거래는 필요한 규제 승인을 받았으며, 2024년 3분기 Astrana의 실적 발표에서 업데이트된 재무 전망이 제공될 것입니다.
Astrana Health, Inc. (NASDAQ: ASTH) a achevé l'acquisition de Collaborative Health Systems (CHS), qui était auparavant une société de Centene (NYSE:CNC). Ce mouvement stratégique élargit le réseau de fournisseurs d'Astrana et ses capacités en matière de soins basés sur la valeur dans 17 états, au service de plus de 129 000 bénéficiaires. L'acquisition vise à :
1. Améliorer la prestation des soins, indépendamment des payeurs, à travers toutes les lignes d'affaires
2. Intégrer des empreintes de providers complémentaires sur des marchés clés
3. Tirer parti de la plateforme d'Habilitation des Soins d'Astrana pour améliorer les résultats pour les patients
Brandon Sim, PDG d'Astrana Health, a souligné que cette acquisition renforcera la position de l'entreprise dans la fourniture de soins de santé de haute qualité et accessibles. La transaction a reçu les approbations réglementaires nécessaires, avec des perspectives financières mises à jour qui seront fournies lors de la conférence téléphonique sur les résultats du troisième trimestre 2024 d'Astrana.
Astrana Health, Inc. (NASDAQ: ASTH) hat die Übernahme von Collaborative Health Systems (CHS) abgeschlossen, das zuvor ein Unternehmen von Centene (NYSE:CNC) war. Dieser strategische Schritt erweitert das Anbieter-Netzwerk von Astrana und die wertbasierte Versorgungsfähigkeit in 17 Bundesstaaten, die über 129.000 Begünstigte betreuen. Das Ziel der Akquisition ist es:
1. Die zahlungsunabhängige Versorgung über alle Geschäftsfelder zu verbessern
2. Komplementäre Anbieter-Präsenzen in Schlüsselmarkt zu integrieren
3. Astranas Care Enablement-Plattform zu nutzen, um die Patientenresultate zu verbessern
Brandon Sim, CEO von Astrana Health, betonte, dass diese Akquisition die Position des Unternehmens in der Bereitstellung hochwertiger, zugänglicher Gesundheitsversorgung stärken wird. Die Transaktion hat die erforderlichen behördlichen Genehmigungen erhalten, und aktualisierte Finanzprognosen werden in Astranas Q3 2024 Ergebnisgespräch bereitgestellt.
- Expansion of Astrana's provider network and value-based care capabilities across 17 states
- Addition of over 129,000 beneficiaries to Astrana's patient base
- Integration of complementary provider footprints in key markets like Connecticut, Georgia, Maryland, New Mexico, and Virginia
- Strengthened presence in Texas with the addition of more than 350 primary care physicians
- Potential for improved patient outcomes through the implementation of Astrana's Care Enablement platform
- None.
"With the completion of our acquisition of CHS, I believe that Astrana will be even better positioned to deliver accessible, high-quality, and high-value care to local communities and patients," said President and CEO of Astrana Health, Brandon Sim. "CHS has built a scaled and impactful value-based care ecosystem in markets spanning the South and East Coast. Combining Astrana's robust technology platform and care model with CHS's strong provider base and deep payer partnerships will accelerate our mutual goal of organizing and empowering providers while elevating the healthcare experience for patients nationwide."
This acquisition facilitates:
- The expansion of both Astrana's and CHS' payer-agnostic care delivery capabilities, which serve members across all lines of business, and further empower CHS' providers in the delivery of care to the communities it serves.
- Integration of a highly complementary provider footprint across several states, including key markets such as
Connecticut ,Georgia ,Maryland ,New Mexico , andVirginia , as well as a scaled ecosystem of more than 350 primary care physicians acrossTexas , where Astrana already has a growing presence. - Astrana's plans to leverage its proven Care Enablement platform, a set of care management tools and technology, including value-based contracting and credentialing, AI-driven population health analytics, its NCQA®-certified Healthcare Effectiveness Data and Information Set gaps in care engine, care management and disease management platform, and other administrative services to further advance improvements in patient outcomes and remove waste from the healthcare system.
The transaction has closed following customary regulatory approvals. The Company will provide an updated financial outlook during its third quarter 2024 earnings call.
Additional details regarding Astrana's acquisition of CHS were shared in its original announcement of the definitive agreement, here, as well as in its second quarter earnings announcement, here.
About Astrana Health, Inc.
Astrana is a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all. Leveraging its proprietary end-to-end technology solutions, Astrana operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver high quality care to patients in a cost-effective manner.
Headquartered in
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements about the Company's ability to realize the intended benefits of the acquisition of CHS, integrate the operations of CHS, and expand its operations. The foregoing number of providers and beneficiaries are estimated as of July 2024. Forward-looking statements reflect current views with respect to future events and financial performance and therefore cannot be guaranteed. Such statements are based on the current expectations and certain assumptions of the Company's management, and some or all of such expectations and assumptions may not materialize or may vary significantly from actual results. Actual results may also vary materially from forward-looking statements due to risks, uncertainties and other factors, known and unknown, including the risk factors described from time to time in the Company's reports to the Securities and Exchange Commission ("SEC"), including without limitation the risk factors discussed in the Company's Annual Report on Form 10-K for the year ended December 31, 2023 and any subsequent quarterly reports on Form 10-Q.
FOR MORE INFORMATION, PLEASE CONTACT:
Astrana Investor Relations
Asher Dewhurst
(626) 943-6491
investors@astranahealth.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/astrana-health-completes-acquisition-of-collaborative-health-systems-302268385.html
SOURCE Astrana Health, Inc.
FAQ
What company did Astrana Health (ASTH) acquire in October 2024?
How many beneficiaries does the acquired company CHS serve?
What are the key markets where Astrana Health (ASTH) will expand its presence through this acquisition?
How many primary care physicians will Astrana Health (ASTH) gain in Texas from this acquisition?
When will Astrana Health (ASTH) provide updated financial outlook following this acquisition?
